Table 2.

Baseline laboratory findings of the study and control group. Groups were compared using chi-square tests for categorical variables, independent-samples student t-tests for normally distributed continuous variables, and Mann–Whitney U tests when the distribution was skewed

Variable	Patients with CAE (n=40)	Control group (n=40)	P
SBP, mm Hg	108.1±19.3	113.9±21.7	0.28
DBP, mm Hg	59.7±9.2	63.4±12.8	0.15
FPG, mg/dL	105 (84–128)	105 (87–144.75)	0.27
LDL, mg/dL	97.7±37.9	88.8±44.2	0.33
HDL, mg/dL	38 (28.25–51.75)	36 (33–39)	0.32
Triglycerides, mg/dL	127 (87–194)	114 (110.5–141.25)	0.92
Hemoglobin, mg/dL	14.5±1.7	15.2±1.9	0.11
MPV, fL	8.8 (8.5–9.3)	8.65 (8.5–9)	0.35
Platelet count, x 109/L	217.8±48.9	227.6±34.3	0.46
Uric acid, mg/dL	6.3±1.6	7±1.8	0.07
Urea, mg/dL	13 (12–17)	14.5 (12–19.75)	0.38
Creatinine, mg/dL	0.79 (0.74–1.14)	0.84 (0.79–0.92)	0.35
NO level, μM	42.1±20.1	77.3±15.7	P<0.001
LVEF, %	56.3±10.4	57.1±9.2	0.73

DBP - diastolic blood pressure; FPG - fasting plasma glucose; HDL - high-density lipoprotein cholesterol; LDL - low-density lipoprotein cholesterol; LVEF - left ventricular ejection fraction; MPV - mean platelet volume; NO - nitric oxide; SBP - systolic blood pressure